These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 9674872

  • 1. Predictive factors of tumor response and prognostic factors of survival during lung cancer chemotherapy.
    Ray P, Quantin X, Grenìer J, Pujol JL.
    Cancer Detect Prev; 1998; 22(4):293-304. PubMed ID: 9674872
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer.
    Pujol JL, Quantin X, Jacot W, Boher JM, Grenier J, Lamy PJ.
    Lung Cancer; 2003 Feb; 39(2):131-8. PubMed ID: 12581564
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Elevated serum NSE level in locally advanced and metastatic NSCLC predispose to better response to chemotherapy but worse survival].
    Załeska M, Szturmowicz M, Zych J, Roszkowska-Sliz B, Demkow U, Langfort R, Roszkowski-Sliz K.
    Pneumonol Alergol Pol; 2010 Feb; 78(1):14-20. PubMed ID: 20162514
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Elevated serum levels of TPS and CYFRA 21-1 predict poor prognosis in advanced non-small-cell lung cancer patients treated with gefitinib.
    Chen F, Luo X, Zhang J, Lu Y, Luo R.
    Med Oncol; 2010 Sep; 27(3):950-7. PubMed ID: 19830603
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
    van Zandwijk N, Jassem E, Bonfrer JM, Mooi WJ, van Tinteren H.
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):37-43. PubMed ID: 1329221
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association between serum biomarkers CEA and LDH and response in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.
    de Jong C, Deneer VHM, Kelder JC, Ruven H, Egberts TCG, Herder GJM.
    Thorac Cancer; 2020 Jul; 11(7):1790-1800. PubMed ID: 32383328
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the serum markers CEA, NSE, TPS and CYFRA 21.1 in lung cancer.
    Giovanella L, Ceriani L, Bandera M, Beghe B, Roncari G.
    Int J Biol Markers; 1995 Jul; 10(3):156-60. PubMed ID: 8551058
    [Abstract] [Full Text] [Related]

  • 18. Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.
    Ardizzoni A, Cafferata MA, Tiseo M, Filiberti R, Marroni P, Grossi F, Paganuzzi M.
    Cancer; 2006 Dec 15; 107(12):2842-9. PubMed ID: 17103443
    [Abstract] [Full Text] [Related]

  • 19. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
    Chakra M, Pujol JL, Lamy PJ, Bozonnat MC, Quantin X, Jacot W, Daurès JP.
    J Thorac Oncol; 2008 Oct 15; 3(10):1119-26. PubMed ID: 18827607
    [Abstract] [Full Text] [Related]

  • 20. The diagnostic and prognostic value of ProGRP in lung cancer.
    Nisman B, Biran H, Ramu N, Heching N, Barak V, Peretz T.
    Anticancer Res; 2009 Nov 15; 29(11):4827-32. PubMed ID: 20032442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.